1. Home
  2. CORT vs NCLH Comparison

CORT vs NCLH Comparison

Compare CORT & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • NCLH
  • Stock Information
  • Founded
  • CORT 1998
  • NCLH 1966
  • Country
  • CORT United States
  • NCLH United States
  • Employees
  • CORT N/A
  • NCLH N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • NCLH Marine Transportation
  • Sector
  • CORT Health Care
  • NCLH Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • NCLH Nasdaq
  • Market Cap
  • CORT 7.1B
  • NCLH 7.1B
  • IPO Year
  • CORT N/A
  • NCLH 2013
  • Fundamental
  • Price
  • CORT $73.36
  • NCLH $19.10
  • Analyst Decision
  • CORT Strong Buy
  • NCLH Buy
  • Analyst Count
  • CORT 4
  • NCLH 18
  • Target Price
  • CORT $142.00
  • NCLH $26.65
  • AVG Volume (30 Days)
  • CORT 1.4M
  • NCLH 15.7M
  • Earning Date
  • CORT 05-05-2025
  • NCLH 04-30-2025
  • Dividend Yield
  • CORT N/A
  • NCLH N/A
  • EPS Growth
  • CORT 8.36
  • NCLH 120.77
  • EPS
  • CORT 1.14
  • NCLH 1.77
  • Revenue
  • CORT $685,446,000.00
  • NCLH $9,415,989,000.00
  • Revenue This Year
  • CORT $35.85
  • NCLH $9.38
  • Revenue Next Year
  • CORT $35.22
  • NCLH $10.38
  • P/E Ratio
  • CORT $64.25
  • NCLH $10.77
  • Revenue Growth
  • CORT 30.93
  • NCLH 5.57
  • 52 Week Low
  • CORT $25.35
  • NCLH $14.21
  • 52 Week High
  • CORT $117.33
  • NCLH $29.29
  • Technical
  • Relative Strength Index (RSI)
  • CORT 55.18
  • NCLH 59.46
  • Support Level
  • CORT $68.86
  • NCLH $16.78
  • Resistance Level
  • CORT $73.36
  • NCLH $19.68
  • Average True Range (ATR)
  • CORT 3.31
  • NCLH 0.63
  • MACD
  • CORT -0.08
  • NCLH 0.39
  • Stochastic Oscillator
  • CORT 75.62
  • NCLH 86.73

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: